ClinicalTrials.Veeva

Menu

The Use of Aromatherapy for Symptom Management

C

Central DuPage Hospital

Status

Unknown

Conditions

Nausea, Vomiting and Anxiety Associated With Medical Oncology Patients

Treatments

Drug: Peppermint and Lavender Essential Oils

Study type

Interventional

Funder types

Other

Identifiers

NCT02163369
14-031-1

Details and patient eligibility

About

The purpose of this pilot study is to introduce the use of aromatherapy/essential oils to medical oncology patients at Central DuPage Hospital to assess their perceived effectiveness to relieve symptoms of nausea or vomiting and/or anxiety.

Peppermint oil will be used for nausea/vomiting and lavender oil will be used for anxiety. This study will involve administration of aromatherapy to a convenience sample of patients, who will then be asked to complete a brief questionnaire. The questionnaire will involve a simple likert scale to measure efficacy (in the opinion of the patient) and simple multiple-choice questions to determine patients' likeliness to use aromatherapy again.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult hospitalized medical oncology patients admitted to Central DuPage Hospital.
  • Age 18 years or greater.
  • Able to understand and speak English.
  • Women of non-childbearing potential or with childbearing potential with a negative pregnancy test documented during the hospital stay.
  • Able to understand concept of aromatherapy for treatment of distressing symptoms.

Exclusion criteria

  • Prisoners.
  • Non-English speaking patients.
  • Under the age of 18.
  • Unable to comprehend the concept of aromatherapy.
  • Severe cognitive impairment.
  • Not experiencing the symptoms of nausea, vomiting or anxiety.
  • Women with child-bearing potential who have not had a negative pregnancy test during the hospital stay.
  • Patients with known allergy to lavender or peppermint.

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

Peppermint and Lavender Essential Oils
Experimental group
Treatment:
Drug: Peppermint and Lavender Essential Oils

Trial contacts and locations

1

Loading...

Central trial contact

Mary Lyons, MSN, APN/CNS, RN-BC, ONC; Lorraine Mack, MSN, RN, CNL, OCN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems